U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Florida Gold Foods LLC - 637153 - 06/21/2023
  1. Warning Letters

CLOSEOUT LETTER

Florida Gold Foods LLC MARCS-CMS 637153 —

Delivery Method:
VIA Electronic Mail
Reference #:
23-HAFE4-WLCOL-03
Product:
Tobacco

Recipient:
Recipient Name
Mr. Ragindra Persaud, Mr. Daniel Sew
Recipient Title
Owner, General Manager
Florida Gold Foods LLC

1770 and 1780 Business Center Lane
Kissimmee, FL 34758-1800
United States

sew@floridagoldfoods.com
Issuing Office:
Division of Human and Animal Food Operations East IV

United States


Dear Mr. Persaud and Mr. Sew:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions as evidenced in our inspection conducted on June 1, 2023. This inspection served as a follow up to our Warning Letter, 23-HAFE4-WL-01 dated November 22, 2022. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Sincerely,
/S/
Pearl Lopina
Director of Compliance Branch OHAFO, Division IV East

Back to Top